MICHAEL Y SY

Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology IRVINE, CA NPI 1376835629

General Payments — all program years on this page

$27,017.50

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 87
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $7,833.77 across 35 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Consulting Fee $6,578.004
Food and Beverage $1,255.7731

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $5,146.4511
2019 $39.152
2021 $3,903.654
2022 $595.1014
2023 $9,499.3821
2024 $7,833.7735

Records — PY2024 (35)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1087159493 Novartis Pharmaceuticals Corporation $0.91 01/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087159495 Novartis Pharmaceuticals Corporation $19.95 01/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087159523 Novartis Pharmaceuticals Corporation $23.02 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087159529 Novartis Pharmaceuticals Corporation $18.75 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087159577 Novartis Pharmaceuticals Corporation $0.68 07/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087159579 Novartis Pharmaceuticals Corporation $23.40 07/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087159587 Novartis Pharmaceuticals Corporation $24.52 08/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087159591 Novartis Pharmaceuticals Corporation $0.49 08/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087159611 Novartis Pharmaceuticals Corporation $0.63 10/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087159613 Novartis Pharmaceuticals Corporation $23.61 10/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087159621 Novartis Pharmaceuticals Corporation $27.75 12/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1093999976 Alexion Pharmaceuticals, Inc. $44.88 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101093284 Celgene Corporation $36.15 11/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101262723 E.R. Squibb & Sons, L.L.C. $1,280.00 12/10/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1104874788 Biogen, Inc. $30.35 03/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105357269 AstraZeneca Pharmaceuticals LP $930.00 04/02/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1105818867 AstraZeneca Pharmaceuticals LP $107.02 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116165249 Amgen Inc. $64.44 07/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133071660 Genentech USA, Inc. $28.04 09/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133071664 Genentech USA, Inc. $55.48 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133071668 Genentech USA, Inc. $22.74 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133071672 Genentech USA, Inc. $2,680.00 02/28/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1133071676 Genentech, Inc. $112.06 02/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133071680 Genentech, Inc. $125.47 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133922065 Vanda Pharmaceuticals Inc. $14.19 10/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133922069 Vanda Pharmaceuticals Inc. $29.45 11/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133922073 Vanda Pharmaceuticals Inc. $29.06 12/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136875992 TG Therapeutics, Inc. $19.56 01/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136876006 TG Therapeutics, Inc. $35.40 02/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136876014 TG Therapeutics, Inc. $20.27 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136876050 TG Therapeutics, Inc. $1,688.00 09/25/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1136876114 TG Therapeutics, Inc. $23.18 10/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136876130 TG Therapeutics, Inc. $119.00 09/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139909635 GENZYME CORPORATION $101.29 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143021373 UCB, Inc. $74.03 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.